Date: 2013-12-02
Type of information: Services contract
Compound:
Company: Novartis (Switzerland) Unilife (USA)
Therapeutic area: Technology - Services
Type agreement:
Action mechanism:
Disease:
Details: * On December 2, 2013, Unilife Corporation, a U.S. based developer and commercial supplier of injectable drug delivery systems, has announced an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis\' targeted early-stage pipeline drugs. Under this agreement, Unilife will supply Novartis with a customized delivery device, consisting of syringe, needle, tubing, controller and pump, to enable administration of a novel investigational Novartis drug into a targeted organ in clinical trials. Unilife has granted Novartis an option for exclusivity under this agreement.
The program to supply customized products for clinical use with Novartis drug candidates is the next phase in a development collaboration between the parties that was commenced in 2011, and continues to progress successfully. Under this agreement Unilife will generate revenue on the basis of the clinical product supplies and activities involved in clinical development.
Financial terms:
Latest news:
